Cargando…
Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver Axis
(1) Background: Fibrosis in early-stage alcohol-associated liver disease (ALD) is commonly under-diagnosed in routine clinical practice. This study characterized the liver-injury and cell death response in alcohol use disorder (AUD) patients with ALD who also exhibited fibrosis and assessed the effi...
Autores principales: | Sagaram, Manasa, Parthasarathy, Ranganathan, Condon, Sally L., Closson, Charles F., Kong, Maiying, Schwandt, Melanie L., Jophlin, Loretta L., Feng, Wenke, Barve, Ashutosh J., Vatsalya, Vatsalya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143806/ https://www.ncbi.nlm.nih.gov/pubmed/35628661 http://dx.doi.org/10.3390/ijms23105852 |
Ejemplares similares
-
Novel paradigms for the gut–brain axis during alcohol withdrawal, withdrawal-associated depression, and craving in patients with alcohol use disorder
por: Vatsalya, Vatsalya, et al.
Publicado: (2023) -
Illustration of Gut–Thyroid Axis in Alcohol Use Disorder: Interplay of Gut Dysfunction, Pro-Inflammatory Responses, and Thyroid Function
por: Sagaram, Manasa, et al.
Publicado: (2022) -
Characterization of Early-Stage Alcoholic Liver Disease with Hyperhomocysteinemia and Gut Dysfunction and Associated Immune Response in Alcohol Use Disorder Patients
por: Vatsalya, Vatsalya, et al.
Publicado: (2020) -
Association of Hypomagnesemia and Liver Injury, Role of Gut-Barrier Dysfunction and Inflammation: Efficacy of Abstinence, and 2-Week Medical Management in Alcohol Use Disorder Patients
por: Winrich, Evan J., et al.
Publicado: (2022) -
Su319 KEY PRO-INFLAMMATORY/INJURY FEATURES OF COVID-19 PATIENTS WITH ALCOHOL USE
por: Rios, Cristian D., et al.
Publicado: (2021)